371 related articles for article (PubMed ID: 27796029)
1. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
Yenilmez C; Ozdemir Koroglu Z; Kurt H; Yanas M; Colak E; Degirmenci I; Gunes HV
J Clin Pharm Ther; 2017 Feb; 42(1):103-107. PubMed ID: 27796029
[TBL] [Abstract][Full Text] [Related]
2. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
Emingil G; Berdeli A; Gürkan A; Han Saygan B; Köse T; Atilla G
J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
[TBL] [Abstract][Full Text] [Related]
3. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
[TBL] [Abstract][Full Text] [Related]
4. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
Gürkan A; Emingil G; Saygan BH; Cinarcik S; Atilla G; Köse T; Berdeli A
J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
[TBL] [Abstract][Full Text] [Related]
5. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
[TBL] [Abstract][Full Text] [Related]
6. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
[TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator and plasminogen activator inhibitor type 1 gene polymorphism in patients with gastric ulcer complicated with bleeding.
Kim HS; Hwang KY; Chung IK; Park SH; Lee MH; Kim SJ; Hong SY
J Korean Med Sci; 2003 Feb; 18(1):58-64. PubMed ID: 12589088
[TBL] [Abstract][Full Text] [Related]
8. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
Prabhudesai A; Shetty S; Ghosh K; Kulkarni B
Eur J Haematol; 2017 Sep; 99(3):249-254. PubMed ID: 28561456
[TBL] [Abstract][Full Text] [Related]
9. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
Fu L; Jin H; Song K; Zhang C; Shen J; Huang Y
Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer.
Błasiak J; Smolarz B
Acta Biochim Pol; 2000; 47(1):191-9. PubMed ID: 10961693
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism in Turkish adult patients with asthma.
Cosan D; Kurt E; Kurt H; Degirmenci I; Kuçukarabaci B; Metintas M; Kucuk MU; Gunes HV; Colak E
Genet Test Mol Biomarkers; 2009 Aug; 13(4):543-6. PubMed ID: 19604112
[TBL] [Abstract][Full Text] [Related]
12. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue-type plasminogen activator gene in atherothrombotic stroke.
Bang CO; Park HK; Ahn MY; Shin HK; Hwang KY; Hong SY
Cerebrovasc Dis; 2001; 11(4):294-9. PubMed ID: 11385207
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.
Espino A; Villagrán A; Vollrath V; Hanckes P; Salas R; Farah A; Solís N; Pizarro M; Escalona A; Boza C; Pérez G; Carrasco G; Padilla O; Miquel JF; Nervi F; Chavez-Tapia NC; Arab JP; Alvarez-Lobos M; Arrese M; Riquelme A
Ann Hepatol; 2011; 10(4):493-501. PubMed ID: 21911891
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.
Eroglu A; Ulu A; Cam R; Akar N
J BUON; 2006; 11(4):481-4. PubMed ID: 17309181
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer.
Smolarz B; Blasiak J; Kulig A; Romanowicz-Makowska H; Dziki A; Ulanska J; Pander B; Szewczyk T
J Exp Clin Cancer Res; 2001 Jun; 20(2):247-52. PubMed ID: 11484982
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis.
Ozbek OY; Ataç FB; Ogus E; Ozbek N
Allergy Asthma Proc; 2009; 30(1):41-6. PubMed ID: 19063817
[TBL] [Abstract][Full Text] [Related]
17. Association of the 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor-1 with abdominal aortic aneurysms.
Rossaak JI; Van Rij AM; Jones GT; Harris EL
J Vasc Surg; 2000 May; 31(5):1026-32. PubMed ID: 10805895
[TBL] [Abstract][Full Text] [Related]
18. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
Reshetniak TM; Ostriakova EV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Seredavkina NV; Volkov AV; Nasonov EL
Ter Arkh; 2013; 85(1):76-84. PubMed ID: 23536951
[TBL] [Abstract][Full Text] [Related]
19. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism and polycystic ovary syndrome.
Kilicci C; Bayram B; Ozkurt M; Onlu H; Erkasap N; Mutlu F
Genet Test Mol Biomarkers; 2011; 15(7-8):565-7. PubMed ID: 21413876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]